Search
Patexia Research
Case number 3:25-cv-00234

ASTRAZENECA PHARMACEUTICALS LP et al v. ZYDUS PHARMACEUTICALS (USA) INC. et al > Documents

Date Field Doc. No.Description (Pages)
Jun 6, 2025 17 LETTER ORDER that the Court finds that the new lawsuits shall be consolidated with 23-cv-796. The Court further finds that the parties' shall disclose their contentions in the standard order outlined in L.Pat.R. 3.6 according to the enclosed schedule. Cases associated. Signed by Magistrate Judge Tonianne J. Bongiovanni on 6/6/2025. (mlh) (Entered: 06/06/2025) (2)
Jun 6, 2025 N/A ***Civil Case Terminated. (mlh) (Entered: 06/06/2025) (0)
Apr 15, 2025 16 ANSWER to Counterclaim by ASTRAZENECA AB, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, KUDOS PHARMACEUTICALS LIMITED, MSD INTERNATIONAL BUSINESS GMBH.(CHEVALIER, CHARLES) (Entered: 04/15/2025) (9)
Mar 17, 2025 14 NOTICE of Appearance by LAUREN BROPHY COOPER on behalf of ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC. (COOPER, LAUREN) (Entered: 03/17/2025) (2)
Mar 17, 2025 15 NOTICE of Appearance by ALEC WONG on behalf of ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC. (WONG, ALEC) (Entered: 03/17/2025) (2)
Mar 13, 2025 13 Application and Proposed Order for Clerk's Order to extend time to answer. (CHEVALIER, CHARLES) (Entered: 03/13/2025) (2)
Mar 13, 2025 N/A Clerk`s Text Order - The document 13 Application for Clerk's Order to Ext Answer/Proposed Order submitted by ASTRAZENECA AB, ASTRAZENECA UK LIMITED, ASTRAZENECA PHARMACEUTICALS LP, KUDOS PHARMACEUTICALS LIMITED, and MSD INTERNATIONAL BUSINESS GMBH has been GRANTED. The answer due date has been set for 4/15/2025. (mlh) (Entered: 03/13/2025) (0)
Mar 11, 2025 11 ANSWER to Complaint Affirmative Defenses and, COUNTERCLAIM against ASTRAZENECA AB, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, KUDOS PHARMACEUTICALS LIMITED, MSD INTERNATIONAL BUSINESS GMBH by ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS LIFESCIENCES LIMITED.(MCCORMICK, THEODORA) (Entered: 03/11/2025) (30)
Mar 11, 2025 12 Corporate Disclosure Statement by ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC.. (MCCORMICK, THEODORA) (Entered: 03/11/2025) (2)
Jan 13, 2025 9 WAIVER OF SERVICE Returned Executed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. ZYDUS PHARMACEUTICALS (USA) INC. waiver sent on 1/10/2025, answer due 3/11/2025. (CHEVALIER, CHARLES) (Entered: 01/13/2025) (1)
Jan 13, 2025 10 WAIVER OF SERVICE Returned Executed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. ZYDUS LIFESCIENCES LIMITED waiver sent on 1/10/2025, answer due 3/11/2025. (CHEVALIER, CHARLES) (Entered: 01/13/2025) (1)
Jan 10, 2025 7 AO120 Patent/Trademark Form filed. (dmr3) (Entered: 01/10/2025) (1)
Jan 10, 2025 8 SUMMONS ISSUED as to ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (dmr3) (Entered: 01/10/2025) (2)
Jan 9, 2025 1 Complaint* (1)
Jan 9, 2025 2 Corporate Disclosure Statement by ASTRAZENECA PHARMACEUTICALS LP identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2)
Jan 9, 2025 3 Corporate Disclosure Statement by ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2)
Jan 9, 2025 4 Corporate Disclosure Statement by ASTRAZENECA AB identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2)
Jan 9, 2025 5 Corporate Disclosure Statement by KUDOS PHARMACEUTICALS LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2)
Jan 9, 2025 6 Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck & Co., Inc. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2)
Jan 9, 2025 N/A Judge Robert Kirsch and Magistrate Judge Tonianne J. Bongiovanni added. (dmr3) (Entered: 01/10/2025) (0)
Menu